前收市價 | 213.99 |
開市 | 212.65 |
買盤 | 213.00 x 800 |
賣出價 | 216.00 x 900 |
今日波幅 | 211.36 - 217.30 |
52 週波幅 | 132.24 - 237.26 |
成交量 | |
平均成交量 | 1,114,903 |
市值 | 31.586B |
Beta 值 (5 年,每月) | 0.67 |
市盈率 (最近 12 個月) | 33.03 |
每股盈利 (最近 12 個月) | 6.51 |
業績公佈日 | 2024年8月01日 - 2024年8月05日 |
遠期股息及收益率 | 1.92 (0.90%) |
除息日 | 2024年5月08日 |
1 年預測目標價 | 212.34 |
Merit Medical (MMSI) benefits from revenue growth in both segments and the majority of its product categories within its Cardiovascular unit in the first quarter.
CVS Health's (CVS) Q1 performance is impacted by a decline in the Health Services segment due to continued pharmacy client price improvements.
ResMed Inc. (NYSE:RMD) Q3 2024 Earnings Call Transcript April 25, 2024 ResMed Inc. beats earnings expectations. Reported EPS is $2.13, expectations were $1.91. ResMed Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello. And welcome to the Q3 Fiscal […]